CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Luminex Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Luminex Corporation
12212 Technology Blvd.
Phone: (512) 249-4741p:512 249-4741 Austin, TX  78727  United States Fax: (512) 219-5195f:512 219-5195
This company was Merged or Acquired on 7/14/2021.
This company ceased filing statements with the SEC on 7/26/2021.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202112/31/2020YesYes--Yes

Industries
SIC Code Description
8731 Commercial physical and biological research
3845 Electromedical and electrotherapeutic apparatus
3841 Surgical and medical instruments and apparatus
6794 Patent owners and lessors

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer NachumShamir 67 8/7/2020 10/14/2014
Chief Financial Officer, Senior Vice President - Finance, Treasurer Harriss T.Currie 59 3/1/2013 10/15/2002
Senior Vice President, General Counsel and Corporate Secretary Richard W.Rew 53 3/1/2015 3/1/2015
10 additional Officers and Directors records available in full report.

Business Names
Business Name
Amnis LLC
ChandlerTec, LLC
IRIS Biotech, LLC
16 additional Business Names available in full report.

General Information
Number of Employees: 1,325 (As of 12/31/2020)
Outstanding Shares: 47,311,982 (As of 5/14/2021)
Shareholders: 477
Stock Exchange: NASD
Federal Tax Id: 742747608
Fax Number: (512) 219-5195
Email Address: info@luminexcorp.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 11, 2024